Scientists think that combining navitoclax with ruxolitinib will help people with myelofibrosis. On this demo half the individuals have navitoclax and ruxolitinib. The opposite 50 % have ruxolitinib and also a dummy drug (placebo ). Also, we selected to irradiate cells 24 h following cell seeding and drug administration to be https://derrickk666xit8.thechapblog.com/profile